SPRI | Rare Kidney Tumors (2019 EN)

Discussion in 'Medicine' started by Kanka, Oct 21, 2018.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,037
    Likes Received:
    449
    Trophy Points:
    83
    [​IMG]

    Author: Gabriel G. Malouf (Editor), Nizar M. Tannir (Editor)
    Full Title: Rare Kidney Tumors: Comprehensive Multidisciplinary Management And Emerging Therapies
    Publisher: Springer; 1st ed. 2019 edition (September 30, 2018)
    Year: 2019
    ISBN-13: 9783319969893 (978-3-319-96989-3), 9783319969886 (978-3-319-96988-6)
    ISBN-10: 3319969897, 3319969889
    Pages: 128
    Language: English
    Genre: Medicine: Oncology
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 71.68 €


    This book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist.

    Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors.

    -------------
     
    Last edited by a moderator: Nov 28, 2019